FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to composition for controlled releasing of drug or vaccine in patient body. Pharmaceutical composition contains stabilized injecting drug or vaccine delivered by particles suspended in biocompatible water-free liquid, wherein said particles comprise of material which stabilizes drug or vaccine and includes soluble glass and calcium phosphate providing sustained releasing of drug or vaccine in circulatory system.
EFFECT: inexpensive and reliable composition for controlled releasing of drug or vaccine in circulatory system.
4 cl, 1 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR DELIVERING STABLE INJECTABLE LIQUIDS AND METHOD FOR DELIVERY | 2000 |
|
RU2259817C2 |
| METHOD OF CONVEYING BIOACTIVE AGENT TO ANIMAL FOR INITIATING IMMUNE RESPONSE | 1989 |
|
RU2127118C1 |
| METHOD FOR DELIVERING BIOLOGICALLY ACTIVE COMPOUND ONTO MUCOSA-ASSOCIATED LYMPHORETICULAR ANIMAL TISSUE, METHOD FOR OBTAINING COMPOSITION AND COMPOSITION FOR DELIVERING BIOLOGICALLY ACTIVE COMPOUND | 1989 |
|
RU2250102C2 |
| ADJUVANT COMPOSITION CONTAINING POLY-GAMMA-GLUTAMIC ACID | 2005 |
|
RU2390352C2 |
| METALLOPROTEINASE OLIGOPEPTIDES AND THEIR THERAPEUTIC USE | 2011 |
|
RU2680717C2 |
| OBTAINING A MICRO/NANOADJUVANT BASED ON RIZEDRONATE ZINC AND ITS USE AS A VACCINE ADJUVANT | 2020 |
|
RU2797509C1 |
| OLIGOPEPTIDES OF METALLOPROTEINASE AND THERAPEUTIC USE THEREOF | 2011 |
|
RU2585388C2 |
| COMPLEX FOR ENHANCING IMMUNE RESPONSE | 2019 |
|
RU2779622C2 |
| IMMUNOSTIMULATING OLIGONUCLEOTIDES | 2009 |
|
RU2477753C2 |
| IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2012 |
|
RU2610690C2 |
